IBI LAUNCHES A CHALLENGE FOR CHILDREN AT EXPLORA: A GAME TO FIND THE RIGHT ANTIBIOTIC
13 October 2017
Rome, 13 October 2017 - “Hi Penelope, here is your new quest: find the right antibiotic to fight the bacteria”. This is the start of the challenge, through fun, that the pharmaceutical company IBI Lorenzini dedicates to children as part of “Economiamo /Let’s save: earn and save, donate and invest, economy has never been that fun!” the economic education game path organised by the children’s museum Museo dei Bambini Explora in collaboration with Fondazione per l’Educazione finanziaria e al risparmio, BNL gruppo Paribas, IBI Lorenzini and TOYOTA Motor Italia spa.
Antibiotics are important drugs used to treat bacterial infections. It is important that the right antibiotic for the infection is always identified. An incorrect use of antibiotics - explains IBI Lorenzini President Camilla Borghese Khevenhüller - can cause resistance to antibiotics.
Every year, resistant bacteria cause approximately 50 thousand deaths, and there is fear of a return to the pre-antibiotic era. This is why it is extremely important to teach children, but also to the adults and teachers that take them through this experience, what are good bacteria and harmful bacteria, and to make them aware, through play, of how to use antibiotics correctly.
The IBI Lorenzini interactive station dedicated to Research explores the world of microorganisms, bacteria and resistance to antibiotics. Through play, children learn how to correctly use antibiotics to treat bacteria, infections, and the appropriate behaviour to prevent infections and resistance to antibiotics. Through an interactive path, children will learn about Salmonella, staphylococci and Streptococcus, which are no fantasy characters, but rather harmful bacteria that we must fight with prevention and the right knowledge, whilst at the same time becoming familiar with friendly bacteria, those that protect us from harmful germs.
As a pharmaceutical company, IBI Lorenzini is strongly committed to increase awareness on appropriate therapy. “Since its creation in 1918,” concludes Camilla Borghese Khevenhüller “we are committed to the importance of applying science and maintain noble intents and dignity of form: this has been our mission for almost a century.”